I’m Chris Anstey, a senior economics editor in Boston, and today we’re looking at the potential economic impact of healthcare advances. Send us feedback and tips to ecodaily@bloomberg.net or get in touch on X via @economics. And if you aren’t yet signed up to receive this newsletter, you can do so here.
Perhaps only second to artificial intelligence over the past year or so has been the investor exuberance over new drugs that combat obesity. And as has happened with AI, economists are now starting to think about the potential for economic implications over time.